Literature DB >> 12147432

Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention.

Stephen S Hecht1.   

Abstract

Much is now known about the carcinogens in cigarette smoke, their conversion to forms that react with DNA, and the miscoding properties of the resulting DNA adducts that cause the many genetic changes known to exist in human lung cancer. The chronic exposure of pulmonary DNA to a multitude of metabolically activated carcinogens is consistent with our current understanding of cancer as a disease resulting from many changes in key genes regulating growth. This review illustrates how this solid foundation of knowledge can be used to find new ways to prevent lung cancer. Three prevention-related topics are discussed: human uptake of tobacco carcinogens as a way of assessing risk and investigating mechanisms; individual differences in the metabolic activation and detoxification of carcinogens, which may relate to cancer susceptibility; and chemoprevention of lung cancer in smokers and ex-smokers. These new approaches are necessary as adjuncts to education and cessation efforts, which despite some success have not eliminated tobacco smoking.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147432     DOI: 10.1016/s1470-2045(02)00815-x

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  141 in total

1.  Development of transcriptomic biomarker signature in human saliva to detect lung cancer.

Authors:  Lei Zhang; Hua Xiao; Hui Zhou; Silverio Santiago; Jay M Lee; Edward B Garon; Jieping Yang; Ole Brinkmann; Xinmin Yan; David Akin; David Chia; David Elashoff; No-Hee Park; David T W Wong
Journal:  Cell Mol Life Sci       Date:  2012-06-12       Impact factor: 9.261

2.  Cyclooxygenase-2 gene and lung carcinoma risk.

Authors:  Ender Coskunpinar; Ilhan Yaylim Eraltan; Akif Turna; Bedia Agachan
Journal:  Med Oncol       Date:  2010-07-20       Impact factor: 3.064

Review 3.  Pharmacological Modulation of Lung Carcinogenesis in Smokers: Preclinical and Clinical Evidence.

Authors:  Silvio De Flora; Gancho Ganchev; Marietta Iltcheva; Sebastiano La Maestra; Rosanna T Micale; Vernon E Steele; Roumen Balansky
Journal:  Trends Pharmacol Sci       Date:  2015-12-23       Impact factor: 14.819

Review 4.  CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.

Authors:  Xin Wang; Kai Yue; Li-Ran Hao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Authors:  Baoyun Xia; Benjamin C Blount; Tonya Guillot; Christina Brosius; Yao Li; Dana M Van Bemmel; Heather L Kimmel; Cindy M Chang; Nicolette Borek; Kathryn C Edwards; Charlie Lawrence; Andrew Hyland; Maciej L Goniewicz; Brittany N Pine; Yang Xia; John T Bernert; B Rey De Castro; John Lee; Justin L Brown; Stephen Arnstein; Diane Choi; Erin L Wade; Dorothy Hatsukami; Gladys Ervies; Angel Cobos; Keegan Nicodemus; Dana Freeman; Stephen S Hecht; Kevin Conway; Lanqing Wang
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

Review 6.  Genomics of lung cancer.

Authors:  Alain C Borczuk; Rebecca L Toonkel; Charles A Powell
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

7.  Metastasis to the F344 Rat Pancreas from Lung Cancer Induced by 4-(Methylnitrosamino)- 1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)- 1-butanol, Constituents of Tobacco Products.

Authors:  Ramesh C Kovi; Charles S Johnson; Silvia Balbo; Stephen S Hecht; M Gerard O'Sullivan
Journal:  Toxicol Pathol       Date:  2018-02-01       Impact factor: 1.902

Review 8.  Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass?

Authors:  Thomas Walle
Journal:  Semin Cancer Biol       Date:  2007-05-13       Impact factor: 15.707

Review 9.  Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.

Authors:  Bhagavatula Moorthy; Chun Chu; Danielle J Carlin
Journal:  Toxicol Sci       Date:  2015-05       Impact factor: 4.849

Review 10.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.